Condition

Meningoccocal Disease (1)

Meningococcal Meningitis (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Novartis Vaccines (1)

Collaborator

GlaxoSmithKline (1)

Intervention

bexsero® vaccine (1 dose at study month zero) (1)

bexsero® vaccine (2 doses 1 month apart) (1)

Study Documents

Intervention Type

biological (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

meningoccocal disease

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Meningoccocal Disease, Meningococcal Meningitis Trial in Hungary, Spain (Bexsero® vaccine (1 dose at study month zero), Bexsero®

Completed

Meningoccocal Disease
Meningococcal Meningitis

Bexsero® vaccine (1 dose at study month zero)
Bexsero® vaccine (2 doses 1 month apart)

Debrecen, Bajcsi Ut 32, Hungary
+16 more

Nov 24, 2021